Kim Yoo Suk, Shin Yoo Seob, Park Do Yang, Choi Jae Won, Park Joo Kyung, Kim Dong Ho, Kim Chul Ho, Park Su A
Department of Otolaryngology, Ajou University School of Medicine, 164 Worldcup Street, Wonchon-Dong, Yeongtong-Gu, Suwon, 442-749, Korea.
Ann Biomed Eng. 2015 Sep;43(9):2153-62. doi: 10.1007/s10439-015-1261-3. Epub 2015 Jan 31.
The role of three-dimensional (3D) printing has expanded in diverse areas in medicine. As plastic surgery needs to fulfill the different demands from diverse individuals, the applications of tailored 3D printing will become indispensable. In this study, we evaluated the feasibility of using 3D-printed polycaprolactone (PCL) scaffold seeded with fibrin/chondrocytes as a new dorsal augmentation material for rhinoplasty. The construct was surgically implanted on the nasal dorsum in the subperiosteal plane of six rabbits. The implants were harvested 4 and 12 weeks after implantation and evaluated by gross morphological assessment, radiographic imaging, and histologic examination. The initial shape of the implant was unchanged in all cases, and no definite post-operative complications were seen over the 3-month period. Radiologic evaluation confirmed that implants remained in the initial location without migration or extrusion. Histologic evaluations showed that the scaffold architectures were maintained with minimal inflammatory reactions; however, expected neo-chondrogenesis was not definite in the constructs. A new PCL scaffold designed by 3D printing method seeded with fibrin/chondrocytes can be a biocompatible augmentation material in rhinoplasty in the future.
三维(3D)打印在医学的各个领域发挥的作用不断扩大。由于整形手术需要满足不同个体的不同需求,定制3D打印的应用将变得不可或缺。在本研究中,我们评估了使用接种纤维蛋白/软骨细胞的3D打印聚己内酯(PCL)支架作为隆鼻术新的鼻背填充材料的可行性。将该构建体通过手术植入6只兔子鼻背的骨膜下平面。在植入后4周和12周取出植入物,并通过大体形态学评估、影像学成像和组织学检查进行评估。所有病例中植入物的初始形状均未改变,在3个月期间未观察到明确的术后并发症。放射学评估证实植入物保留在初始位置,无移位或挤出。组织学评估显示支架结构得以维持,炎症反应轻微;然而,构建体中预期的新软骨形成并不明确。通过3D打印方法设计的接种纤维蛋白/软骨细胞的新型PCL支架未来可能成为隆鼻术中具有生物相容性的填充材料。